A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection
Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was conducted on ascending aorta samples from AD patients versus those from control subjects using proteomic analysis. Integrated proteomic data an...
Saved in:
| Published in | Pharmacological research Vol. 199; p. 107029 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier
01.01.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was conducted on ascending aorta samples from AD patients versus those from control subjects using proteomic analysis. Integrated proteomic data analysis identified S100 calcium-binding proteins A8 and A9 (S100A8/A9) as new therapeutic targets for AD. As assessed by ELISA, the circulating levels of S100A8/A9 were elevated in AD patients. In addition, we validated the upregulation of S100A8/A9 in a mouse model of AD. In vitro and in vivo studies substantiated that S100A8/A9, as danger-associated molecular pattern molecules, promotes the smooth muscle cells phenotypic switch by inhibiting serum response factor (SRF) activity but elevating NF-κB dependent inflammatory response. Depletion of S100A8/A9 attenuates the occurrence and development of AD. As a proof of concept, we tested the safety and efficacy of pharmacological inhibition of S100A8/A9 by ABR-25757 (paquinimod) in a mouse model of AD. We observed that ABR-25757 ameliorated the incidence of rupture and improved elastin morphology associated with AD. Further single-cell RNA sequencing disclosed that the phenotypic switch of vascular smooth muscle cells (VSMCs) and inflammatory response pathways were responsible for ABR-25757-mediated protection against AD. Thus, this study reveals the regulatory mechanism of S100A8/A9 in AD and offers a potential therapeutic avenue to treat AD by targeting S100A8/A9. |
|---|---|
| AbstractList | Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was conducted on ascending aorta samples from AD patients versus those from control subjects using proteomic analysis. Integrated proteomic data analysis identified S100 calcium-binding proteins A8 and A9 (S100A8/A9) as new therapeutic targets for AD. As assessed by ELISA, the circulating levels of S100A8/A9 were elevated in AD patients. In addition, we validated the upregulation of S100A8/A9 in a mouse model of AD. In vitro and in vivo studies substantiated that S100A8/A9, as danger-associated molecular pattern molecules, promotes the smooth muscle cells phenotypic switch by inhibiting serum response factor (SRF) activity but elevating NF-κB dependent inflammatory response. Depletion of S100A8/A9 attenuates the occurrence and development of AD. As a proof of concept, we tested the safety and efficacy of pharmacological inhibition of S100A8/A9 by ABR-25757 (paquinimod) in a mouse model of AD. We observed that ABR-25757 ameliorated the incidence of rupture and improved elastin morphology associated with AD. Further single-cell RNA sequencing disclosed that the phenotypic switch of vascular smooth muscle cells (VSMCs) and inflammatory response pathways were responsible for ABR-25757-mediated protection against AD. Thus, this study reveals the regulatory mechanism of S100A8/A9 in AD and offers a potential therapeutic avenue to treat AD by targeting S100A8/A9.Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was conducted on ascending aorta samples from AD patients versus those from control subjects using proteomic analysis. Integrated proteomic data analysis identified S100 calcium-binding proteins A8 and A9 (S100A8/A9) as new therapeutic targets for AD. As assessed by ELISA, the circulating levels of S100A8/A9 were elevated in AD patients. In addition, we validated the upregulation of S100A8/A9 in a mouse model of AD. In vitro and in vivo studies substantiated that S100A8/A9, as danger-associated molecular pattern molecules, promotes the smooth muscle cells phenotypic switch by inhibiting serum response factor (SRF) activity but elevating NF-κB dependent inflammatory response. Depletion of S100A8/A9 attenuates the occurrence and development of AD. As a proof of concept, we tested the safety and efficacy of pharmacological inhibition of S100A8/A9 by ABR-25757 (paquinimod) in a mouse model of AD. We observed that ABR-25757 ameliorated the incidence of rupture and improved elastin morphology associated with AD. Further single-cell RNA sequencing disclosed that the phenotypic switch of vascular smooth muscle cells (VSMCs) and inflammatory response pathways were responsible for ABR-25757-mediated protection against AD. Thus, this study reveals the regulatory mechanism of S100A8/A9 in AD and offers a potential therapeutic avenue to treat AD by targeting S100A8/A9. Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was conducted on ascending aorta samples from AD patients versus those from control subjects using proteomic analysis. Integrated proteomic data analysis identified S100 calcium-binding proteins A8 and A9 (S100A8/A9) as new therapeutic targets for AD. As assessed by ELISA, the circulating levels of S100A8/A9 were elevated in AD patients. In addition, we validated the upregulation of S100A8/A9 in a mouse model of AD. In vitro and in vivo studies substantiated that S100A8/A9, as danger-associated molecular pattern molecules, promotes the smooth muscle cells phenotypic switch by inhibiting serum response factor (SRF) activity but elevating NF-κB dependent inflammatory response. Depletion of S100A8/A9 attenuates the occurrence and development of AD. As a proof of concept, we tested the safety and efficacy of pharmacological inhibition of S100A8/A9 by ABR-25757 (paquinimod) in a mouse model of AD. We observed that ABR-25757 ameliorated the incidence of rupture and improved elastin morphology associated with AD. Further single-cell RNA sequencing disclosed that the phenotypic switch of vascular smooth muscle cells (VSMCs) and inflammatory response pathways were responsible for ABR-25757-mediated protection against AD. Thus, this study reveals the regulatory mechanism of S100A8/A9 in AD and offers a potential therapeutic avenue to treat AD by targeting S100A8/A9. |
| ArticleNumber | 107029 |
| Author | Zhang, Zhidan Su, Meiming Wang, Li Xu, Suowen Jiang, Hui Sun, Lu Zhao, Yaping Wang, Zhihua Little, Peter J. Ge, Jianjun Ilyas, Iqra Weng, Jianping Chen, Meijie |
| Author_xml | – sequence: 1 givenname: Hui surname: Jiang fullname: Jiang, Hui – sequence: 2 givenname: Yaping surname: Zhao fullname: Zhao, Yaping – sequence: 3 givenname: Meiming surname: Su fullname: Su, Meiming – sequence: 4 givenname: Lu surname: Sun fullname: Sun, Lu – sequence: 5 givenname: Meijie surname: Chen fullname: Chen, Meijie – sequence: 6 givenname: Zhidan surname: Zhang fullname: Zhang, Zhidan – sequence: 7 givenname: Iqra surname: Ilyas fullname: Ilyas, Iqra – sequence: 8 givenname: Zhihua surname: Wang fullname: Wang, Zhihua – sequence: 9 givenname: Peter J. surname: Little fullname: Little, Peter J. – sequence: 10 givenname: Li surname: Wang fullname: Wang, Li – sequence: 11 givenname: Jianping surname: Weng fullname: Weng, Jianping – sequence: 12 givenname: Jianjun surname: Ge fullname: Ge, Jianjun – sequence: 13 givenname: Suowen surname: Xu fullname: Xu, Suowen |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38056513$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UctuFDEQHKEg8oAf4IB85JDZ-DUe-7iKSIgUiQNwtjx2z8arWXuxPaD8BN-MJ5Nw4MCpW6Wq6lLXeXMSYoCmeU_whmAirvab40PKG4opq0CPqXrVnBGsREuIFCfLzlkrBJGnzXnOe4yx4gS_aU6ZxJ3oCDtrfm_RMcUC8QDtL-8AZZsAAqprKH70kFF5AGTNZP18QIMPzofdqvEhX6KvBOOtvHoa6hKZjOzkg6-C6RElmOCnCWXxSOYIc_EWFZN2UDLyAZmYFsT5nMEWH8Pb5vVopgzvnudF8_3m07frz-39l9u76-19azlhpaWMEsMGOUrVGzWOznSEK9cNHARVTg5uHMRAHZdUCUoxHruK0g66Hihzgl00d6uvi2avj8kfTHrU0Xj9BMS002aJNoEmfCBSuYFyTrmlfGA9KMOF7K0ce4qr18fVqz7lxwy56IPPFqbJBIhz1lQqxfqu5wv1wzN1Hg7g_h5-6aMS5EqwKeacYNTWF7N8piTjJ02wXqrXNXOtXi_V67X6KqX_SF_c_yP6A93ispU |
| CitedBy_id | crossref_primary_10_1016_j_cellsig_2024_111199 crossref_primary_10_1016_j_jaccao_2024_10_010 crossref_primary_10_1016_j_jcmgh_2025_101486 crossref_primary_10_3390_cimb46090577 |
| Cites_doi | 10.1038/nm1638 10.1182/blood.2021014966 10.12659/MSM.909641 10.1038/s41590-023-01656-1 10.4049/jimmunol.1402301 10.1161/CIRCRESAHA.109.209486 10.1161/CIRCRESAHA.116.304918 10.1371/journal.pbio.1000097 10.1093/ejcts/ezab546 10.1136/annrheumdis-2014-206517 10.3389/fcvm.2021.614757 10.1016/j.jacc.2012.04.027 10.1016/j.pharmthera.2016.07.015 10.2174/156652413804486214 10.1038/s41584-018-0058-9 10.1126/scitranslmed.abn5939 10.1186/s12967-016-0774-3 10.1016/j.jdermsci.2016.04.006 10.1016/j.chom.2020.12.016 10.1016/j.jacc.2015.05.029 10.1177/1535370216681551 10.1002/ehf2.12760 10.1161/CIRCULATIONAHA.119.043833 10.1189/jlb.0306170 10.1161/CIRCULATIONAHA.118.039262 10.1038/s41569-019-0326-7 10.1002/JLB.3COVCRA0720-359R |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| Copyright_xml | – notice: Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| DBID | AAYXX CITATION NPM 7X8 DOA |
| DOI | 10.1016/j.phrs.2023.107029 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1096-1186 |
| ExternalDocumentID | oai_doaj_org_article_14b189db24424c24b37e9a4687c8f720 38056513 10_1016_j_phrs_2023_107029 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .GJ .~1 0R~ 0ZK 123 1B1 1RT 1~. 1~5 29O 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO AAYXX ABFNM ABFRF ABJNI ABMAC ABOCM ABWVN ABXDB ABZDS ACDAQ ACGFO ACGFS ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFGL ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AFJKZ AFPUW AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRNS AGUBO AGYEJ AHHHB AIEXJ AIGII AIIUN AIKHN AITUG AKBMS AKRWK AKYEP ALCLG ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CAG CITATION COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HMT HVGLF HX~ HZ~ IHE J1W KOM L7B LG5 M33 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SPT SSH SSP SSZ T5K TEORI UNMZH WUQ XPP ZU3 ZXP ~G- AACTN AFKWA AJOXV AMFUW NPM 7X8 EFKBS |
| ID | FETCH-LOGICAL-c413t-2321a3b8f897a9ffda5149d5b4e629d8bdfb6b2d482962200f59d825e57e23d63 |
| IEDL.DBID | DOA |
| ISSN | 1043-6618 1096-1186 |
| IngestDate | Wed Aug 27 01:19:45 EDT 2025 Fri Jul 11 10:20:32 EDT 2025 Wed Feb 19 02:07:21 EST 2025 Thu Apr 24 23:00:09 EDT 2025 Tue Jul 01 03:33:57 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Pharmacotherapy Aortic dissection S100A9 S100A8 |
| Language | English |
| License | Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c413t-2321a3b8f897a9ffda5149d5b4e629d8bdfb6b2d482962200f59d825e57e23d63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/14b189db24424c24b37e9a4687c8f720 |
| PMID | 38056513 |
| PQID | 2899375740 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_14b189db24424c24b37e9a4687c8f720 proquest_miscellaneous_2899375740 pubmed_primary_38056513 crossref_citationtrail_10_1016_j_phrs_2023_107029 crossref_primary_10_1016_j_phrs_2023_107029 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-01-00 2024-Jan 20240101 2024-01-01 |
| PublicationDateYYYYMMDD | 2024-01-01 |
| PublicationDate_xml | – month: 01 year: 2024 text: 2024-01-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Pharmacological research |
| PublicationTitleAlternate | Pharmacol Res |
| PublicationYear | 2024 |
| Publisher | Elsevier |
| Publisher_xml | – name: Elsevier |
| References | Chen (10.1016/j.phrs.2023.107029_bib12) 2018; 24 Guo (10.1016/j.phrs.2023.107029_bib15) 2021; 29 Nienaber (10.1016/j.phrs.2023.107029_bib1) 2016; 2 Colicchia (10.1016/j.phrs.2023.107029_bib28) 2022; 140 Gao (10.1016/j.phrs.2023.107029_bib4) 2021; 8 Anzai (10.1016/j.phrs.2023.107029_bib2) 2015; 116 Li (10.1016/j.phrs.2023.107029_bib24) 2019; 140 Shi (10.1016/j.phrs.2023.107029_bib27) 2021; 109 Pruenster (10.1016/j.phrs.2023.107029_bib29) 2023 Pruenster (10.1016/j.phrs.2023.107029_bib25) 2016; 167 Narumi (10.1016/j.phrs.2023.107029_bib23) 2015; 194 Silvestre-Roig (10.1016/j.phrs.2023.107029_bib8) 2020; 17 Stenström (10.1016/j.phrs.2023.107029_bib13) 2016; 83 Sreejit (10.1016/j.phrs.2023.107029_bib17) 2020; 141 Wang (10.1016/j.phrs.2023.107029_bib20) 2018; 9 Ometto (10.1016/j.phrs.2023.107029_bib21) 2017; 242 Schelbergen (10.1016/j.phrs.2023.107029_bib14) 2015; 74 Pape (10.1016/j.phrs.2023.107029_bib3) 2015; 66 Hemli (10.1016/j.phrs.2023.107029_bib5) 2022; 61 Foell (10.1016/j.phrs.2023.107029_bib18) 2007; 81 Das (10.1016/j.phrs.2023.107029_bib32) 2012; 60 Björk (10.1016/j.phrs.2023.107029_bib16) 2009; 7 Amaya-Garrido (10.1016/j.phrs.2023.107029_bib30) 2023; 15 Donato R (10.1016/j.phrs.2023.107029_bib19) 2013; 13 Hofmann Bowman (10.1016/j.phrs.2023.107029_bib31) 2010; 106 Bai (10.1016/j.phrs.2023.107029_bib9) 2021; 8 Vogl (10.1016/j.phrs.2023.107029_bib22) 2007; 13 Austermann (10.1016/j.phrs.2023.107029_bib6) 2018; 14 Raphael (10.1016/j.phrs.2023.107029_bib10) 2016; 14 Sacks (10.1016/j.phrs.2023.107029_bib26) 2018; 13 Müller (10.1016/j.phrs.2023.107029_bib11) 2020; 7 Wang (10.1016/j.phrs.2023.107029_bib7) 2021; 2021 |
| References_xml | – volume: 13 start-page: 1042 year: 2007 ident: 10.1016/j.phrs.2023.107029_bib22 article-title: Mrp8 and mrp14 are endogenous activators of toll-like receptor 4, promoting lethal, endotoxin-induced shock publication-title: Nat. Med doi: 10.1038/nm1638 – volume: 140 start-page: 2626 year: 2022 ident: 10.1016/j.phrs.2023.107029_bib28 article-title: S100a8/a9 drives the formation of procoagulant platelets through gpibα publication-title: Blood doi: 10.1182/blood.2021014966 – volume: 8 year: 2021 ident: 10.1016/j.phrs.2023.107029_bib4 article-title: Analysis of hub genes and the mechanism of immune infiltration in stanford type a aortic dissection publication-title: Front. Cardiovasc. Med. – volume: 24 start-page: 7673 year: 2018 ident: 10.1016/j.phrs.2023.107029_bib12 article-title: Arterial thrombosis is accompanied by elevated mitogen-activated protein kinase (mapk) and cyclooxygenase-2 (cox-2) expression via toll-like receptor 4 (tlr-4) activation by s100a8/a9 publication-title: Med Sci. Monit. doi: 10.12659/MSM.909641 – year: 2023 ident: 10.1016/j.phrs.2023.107029_bib29 article-title: E-selectin-mediated rapid nlrp3 inflammasome activation regulates s100a8/s100a9 release from neutrophils via transient gasdermin d pore formation publication-title: Nat. Immunol. doi: 10.1038/s41590-023-01656-1 – volume: 194 start-page: 5539 year: 2015 ident: 10.1016/j.phrs.2023.107029_bib23 article-title: Proinflammatory proteins s100a8/s100a9 activate nk cells via interaction with rage publication-title: J. Immunol. doi: 10.4049/jimmunol.1402301 – volume: 9 year: 2018 ident: 10.1016/j.phrs.2023.107029_bib20 article-title: S100a8/a9 in inflammation publication-title: Front Immunol. – volume: 106 start-page: 145 year: 2010 ident: 10.1016/j.phrs.2023.107029_bib31 article-title: S100a12 mediates aortic wall remodeling and aortic aneurysm publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.109.209486 – volume: 116 start-page: 612 year: 2015 ident: 10.1016/j.phrs.2023.107029_bib2 article-title: Adventitial cxcl1/g-csf expression in response to acute aortic dissection triggers local neutrophil recruitment and activation leading to aortic rupture publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.304918 – volume: 7 year: 2009 ident: 10.1016/j.phrs.2023.107029_bib16 article-title: Identification of human s100a9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides publication-title: PLoS Biol. doi: 10.1371/journal.pbio.1000097 – volume: 61 start-page: 838 year: 2022 ident: 10.1016/j.phrs.2023.107029_bib5 article-title: Management of acute type a aortic dissection in the elderly: An analysis from irad publication-title: Eur. J. Cardio-Thorac. Surg.: Off. J. Eur. Assoc. Cardio-Thorac. Surg. doi: 10.1093/ejcts/ezab546 – volume: 74 start-page: 2254 year: 2015 ident: 10.1016/j.phrs.2023.107029_bib14 article-title: Prophylactic treatment with s100a9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2014-206517 – volume: 8 year: 2021 ident: 10.1016/j.phrs.2023.107029_bib9 article-title: High neutrophil to lymphocyte ratio and its gene signatures correlate with diastolic dysfunction in heart failure with preserved ejection fraction publication-title: Front Cardiovasc Med doi: 10.3389/fcvm.2021.614757 – volume: 60 start-page: 775 year: 2012 ident: 10.1016/j.phrs.2023.107029_bib32 article-title: S100a12 expression in thoracic aortic aneurysm is associated with increased risk of dissection and perioperative complications publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2012.04.027 – volume: 13 start-page: 612 year: 2018 ident: 10.1016/j.phrs.2023.107029_bib26 article-title: Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke publication-title: Int J. Stroke – volume: 167 start-page: 120 year: 2016 ident: 10.1016/j.phrs.2023.107029_bib25 article-title: S100a8/a9: From basic science to clinical application publication-title: Pharm. Ther. doi: 10.1016/j.pharmthera.2016.07.015 – volume: 13 start-page: 24 year: 2013 ident: 10.1016/j.phrs.2023.107029_bib19 article-title: Functions of s100 proteins publication-title: Curr. Mol. Med. doi: 10.2174/156652413804486214 – volume: 14 start-page: 528 year: 2018 ident: 10.1016/j.phrs.2023.107029_bib6 article-title: S100 proteins in rheumatic diseases publication-title: Nat. Rev. Rheuma doi: 10.1038/s41584-018-0058-9 – volume: 2021 year: 2021 ident: 10.1016/j.phrs.2023.107029_bib7 article-title: Identification of potential biomarkers associated with acute myocardial infarction by weighted gene coexpression network analysis publication-title: Oxid. Med Cell Longev. – volume: 15 year: 2023 ident: 10.1016/j.phrs.2023.107029_bib30 article-title: Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.abn5939 – volume: 2 year: 2016 ident: 10.1016/j.phrs.2023.107029_bib1 article-title: Aortic dissection publication-title: Nat. Rev. Dis. Prim. – volume: 14 year: 2016 ident: 10.1016/j.phrs.2023.107029_bib10 article-title: Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction publication-title: J. Transl. Med doi: 10.1186/s12967-016-0774-3 – volume: 83 start-page: 52 year: 2016 ident: 10.1016/j.phrs.2023.107029_bib13 article-title: Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis publication-title: J. Dermatol. Sci. doi: 10.1016/j.jdermsci.2016.04.006 – volume: 29 start-page: 222 year: 2021 ident: 10.1016/j.phrs.2023.107029_bib15 article-title: Induction of alarmin s100a8/a9 mediates activation of aberrant neutrophils in the pathogenesis of covid-19 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2020.12.016 – volume: 66 start-page: 350 year: 2015 ident: 10.1016/j.phrs.2023.107029_bib3 article-title: Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2015.05.029 – volume: 242 start-page: 859 year: 2017 ident: 10.1016/j.phrs.2023.107029_bib21 article-title: Calprotectin in rheumatic diseases publication-title: Exp. Biol. Med (Maywood) doi: 10.1177/1535370216681551 – volume: 7 start-page: 1442 year: 2020 ident: 10.1016/j.phrs.2023.107029_bib11 article-title: Serum alarmin s100a8/s100a9 levels and its potential role as biomarker in myocarditis publication-title: ESC Heart Fail doi: 10.1002/ehf2.12760 – volume: 141 start-page: 1080 year: 2020 ident: 10.1016/j.phrs.2023.107029_bib17 article-title: Neutrophil-derived s100a8/a9 amplify granulopoiesis after myocardial infarction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.119.043833 – volume: 81 start-page: 28 year: 2007 ident: 10.1016/j.phrs.2023.107029_bib18 article-title: S100 proteins expressed in phagocytes: A novel group of damage-associated molecular pattern molecules publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.0306170 – volume: 140 start-page: 751 year: 2019 ident: 10.1016/j.phrs.2023.107029_bib24 article-title: S100a8/a9 signaling causes mitochondrial dysfunction and cardiomyocyte death in response to ischemic/reperfusion injury publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.118.039262 – volume: 17 start-page: 327 year: 2020 ident: 10.1016/j.phrs.2023.107029_bib8 article-title: Neutrophils as regulators of cardiovascular inflammation publication-title: Nat. Rev. Cardiol. doi: 10.1038/s41569-019-0326-7 – volume: 109 start-page: 67 year: 2021 ident: 10.1016/j.phrs.2023.107029_bib27 article-title: Neutrophil calprotectin identifies severe pulmonary disease in covid-19 publication-title: J. Leukoc. Biol. doi: 10.1002/JLB.3COVCRA0720-359R |
| SSID | ssj0009410 |
| Score | 2.4531715 |
| Snippet | Aortic dissection (AD) is a fatal cardiovascular disease with limited pharmacotherapies. To discover novel therapeutic targets for AD, the present study was... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 107029 |
| SubjectTerms | Aortic dissection Pharmacotherapy S100A8 S100A9 |
| Title | A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/38056513 https://www.proquest.com/docview/2899375740 https://doaj.org/article/14b189db24424c24b37e9a4687c8f720 |
| Volume | 199 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pa9swFBajp17G1nZb1h-8QsllMbUlWZaOaWkphZbAEujNSJYMHq0zloSSf6J_c58kO-ml22Ung5AsWe9J73vWe58IOasEKoHG3U8ZlybcFTox1tUJFzWa51w5pn2-8929uJnx24f84c1VXz4mLNIDx4k7z7jJpLIGzRDlFeWGFU5pjl1Usi5o8NbR5vXOVE-3y7O0S5GJ0Vw4M56cmzIsKNIAKLdmKLD1vw8xg6m5_kQ-dhgRxnFsn8kH1-6R4SSSTK9HMN3mTC1GMITJln56vU9exhDIF-ZPLnlurAPcGNBZhcbGwCC3AAR9gLKpmtUTmCbktcQ2TYsv_Jml6Vieh4cagV5Anz75uAZ_xwqC7yW8SdyCGE6-gKYFPfejhnDMH1ImDsjs-mp6eZN0ty4kFRq0ZYIQK9PMyFqqQqu6thqFpmxuuBNUWWlsbYShlkuqBMVFVudYSnOXF44yK9gXstPOW_eNgBDSoMBYppXgKZMabR86cL7MVk4VA5L1QiirjpLc34zxWPaxZ79KL7jSC66MghuQH5s2vyMhx19rX3jZbmp6Mu1QgCpWdipW_kvFBuS014wSF58_UdGtm6-wJ-nhXV5wrPM1qsymKyYRW-YZ-_4_hnBIdvGrePz3c0R2ln9W7hjR0NKcBMV_BTTZBrE |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+proteome-wide+screen+identifies+the+calcium+binding+proteins%2C+S100A8%2FS100A9%2C+as+clinically+relevant+therapeutic+targets+in+aortic+dissection&rft.jtitle=Pharmacological+research&rft.au=Jiang%2C+Hui&rft.au=Zhao%2C+Yaping&rft.au=Su%2C+Meiming&rft.au=Sun%2C+Lu&rft.date=2024-01-01&rft.issn=1096-1186&rft.eissn=1096-1186&rft.volume=199&rft.spage=107029&rft_id=info:doi/10.1016%2Fj.phrs.2023.107029&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-6618&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-6618&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-6618&client=summon |